24/7 Patient Assistance: 760-405-8205

Randolph J. Hecht, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. J. Randolph Hecht is a medical oncology specialist in Santa Monica, California and he works at several hospitals in the area, including UCLA Medical Center and St. John's Health Center. He got his diploma from Eastern Virginia Medical School and did his residency in internal medicine at McGaw Medical Center of Northwestern University. He also did a fellowship in gastroenterology at UCLA Medical Center. The doctor is certified in internal medicine and has an experience of more than 20 years.

  • Education & Training


    Eastern Virginia Medical School

    Medical School


    McGaw Medical Center of Northwestern University



    UCLA Medical Center


  • Board Certifications

    American Board of Internal Medicine

  • Hospital & Practice

    Providence Saint John's Health Center

    Languages: English/Spanish

    (310) 829-5511

    2121 Santa Monica Boulevard

    Santa Monica, California 90404

    Read More

    Ronald Reagan UCLA Medical Center

    Languages: English/Spanish

    (310) 825-9111

    757 Westwood Plaza

    Los Angeles, California 90095

    Read More

    UCLA Medical Center, Santa Monica

    Languages: English/Spanish

    (424) 259-6000

    1250 16th St

    Santa Monica, California 90404

    Read More
  • Publications & Memberships

    Dr. Randolph J. Hecht has contributed to 3 publications.

    Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroe...

    Hecht, J. R.,Bang, Y. J.,Qin, S. K.,Chung, H. C.,Xu, J. M.,Park, J. O.,Jeziorski, K.,Shparyk, Y.,Hoff, P. M.,Sobrero, A.,Salman, P.,Li, J.,Protsenko, S. A.,Wainberg, Z...; J. Clin. Oncol.. 2015 Dec 03.

    See more >>

    Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy.

    Harrington, K. J.,Puzanov, I.,Hecht, J. R.,Hodi, F. S.,Szabo, Z.,Murugappan, S.,Kaufman, H. L.; Expert Rev Anticancer Ther. 2015 Nov 13.

    See more >>

    A Single Institution Experience in Compliance with Universal Screening for Lynch Syndrome in Colorectal Cancer.

    Hill, A. L.,Sumra, K. K.,Russell, M. M.,Yoo, J.,Ko, C. Y.,Hart, S.,Wainberg, Z.,Hecht, J. R.,Lin, A. Y.; J. Gastrointest. Surg.. 2014 Dec 17.

    See more >>


    American Society of Clinical Oncology